Sally has wealth of experience working with businesses at the cutting edge of research and technology and whose intellectual property is of prime importance.
Sally is one of the firm’s leading intellectual property (IP) partners. She provides a full range of intellectual property commercial advice and support to her clients, including licensing, partnering and exploitation agreements, research, development and marketing collaborations. She also frequently advises clients on regulatory and ‘freedom to operate’ matters, and manages significant due diligence matters. As a transactional intellectual property lawyer, she provides advice in relation to the protection and exploitation of a full range of IP rights, both in stand alone transactions and as part of an acquisition, divestment or investment activity.
Before joining the firm in 2006, Sally was head of IP and life sciences at Eversheds, and prior to that she spent 11 years working in-house, firstly as senior legal adviser at ICI/Zeneca and latterly as Legal Director of Novartis UK. This in-house experience gave her significant insight into the need to give pragmatic and commercial advice.
Sally speaks on a variety of IP and regulatory life sciences topics at conferences and contributes to many leading publications; she is also the editor of The Guide to EU Pharmaceutical Regulatory Law (published by Kluwer Law International), which is written entirely by the team at Bird & Bird with contributions from many offices. Sally is also leading the Bird & Bird Brexit steering committee; she gives regular talks and has published several articles on the implications of Brexit for the life sciences and medical devices industries
Chambers UK (2016) says: “Sally Shorthose leads the firm's commercial and transactional IP work and is a life sciences sector stalwart. A client says: ‘I have appreciated her practical and business-minded approach to our legal issues.’”
Chambers UK (2017) says: "Sally Shorthose is recommended for commercial, IP-based transactions within the sector. She also has experience advising on public securities offerings, joint venture formations and regulatory compliance."
IAM Patent 1000 (2016) says: "Having spent 11 years working in-house – first at ICI/Zeneca and then at Novartis – she is truly experienced in pharmaceutical matters."
WWL says: The highly-recommended Sally Shorthose focuses on commercial and licensing matters in the life sciences sector, including due diligence and R&D work.
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.